# CME Group Inc.: Form 10-Q for the period ended Sep 30, 2025

- Company: [CME Group Inc.](/companies/cme.md) (CIK 1156375)
- Form: 10-Q
- Filed: 2025-10-24
- Accepted by EDGAR: Oct 24, 2025, 14:07 ET
- Period: 2025-09-30
- Accession: 0001156375-25-000206
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1156375/000115637525000206/cme-20250930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1156375/000115637525000206/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2025-07-01 to 2025-09-30 | $1.54bn | us-gaap:Revenues |
| Revenue | 9 months, 2025-01-01 to 2025-09-30 | $4.87bn | us-gaap:Revenues |
| Operating income | 3 months, 2025-07-01 to 2025-09-30 | $972.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2025-01-01 to 2025-09-30 | $3.21bn | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2025-07-01 to 2025-09-30 | $269.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2025-01-01 to 2025-09-30 | $862.8m | us-gaap:IncomeTaxExpenseBenefit |
| Diluted EPS | 3 months, 2025-07-01 to 2025-09-30 | $2.49 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2025-01-01 to 2025-09-30 | $7.92 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2025-07-01 to 2025-09-30 | $2.49 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2025-01-01 to 2025-09-30 | $7.93 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2025-07-01 to 2025-09-30 | 360,422,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2025-01-01 to 2025-09-30 | 360,330,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2025-01-01 to 2025-09-30 | $3.14bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2025-01-01 to 2025-09-30 | $51.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2025-01-01 to 2025-09-30 | $3.48bn | us-gaap:PaymentsOfDividends |
| Cash and equivalents | at 2025-09-30 | $2.45bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2025-09-30 | $152.80bn | us-gaap:AssetsCurrent |
| Total assets | at 2025-09-30 | $187.14bn | us-gaap:Assets |
| Current liabilities | at 2025-09-30 | $149.59bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2025-09-30 | $158.95bn | us-gaap:Liabilities |
| Short-term borrowings | at 2025-09-30 | $0 | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2025-09-30 | $28.19bn | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1156375/000115637525000206/cme-20250930.htm

Filed Oct 24, 2025.
Source: SEC EDGAR, the filing index for accession 0001156375-25-000206. Last ingested by Listed: Nov 3, 2026, 22:14 ET. No prices; not investment advice.